Benjamin Warner, MS, PhD, Department of Epidemiology Liquid biopsy for cancer prevention: Can Epstein-Barr virus serology stratify nasopharyngeal carcinoma risk This seminar has been created as a platform for postdoctoral scholars and junior researchers to discuss their research/work, give talks, and have an opportunity for peer discussions. If you are interested in showcasing your research, […]
Asma Cheema, MBBS; MPhil; PhD, Department of Human Genetics Search for the elusive haplotype of the APOE polymorphism associated with Alzheimers disease This seminar has been created as a platform for postdoctoral scholars and junior researchers to discuss their research/work, give talks, and have an opportunity for peer discussions. If you are interested in showcasing […]
Noah Herrick, PhD, Department of Human Genetics, Center for Craniofacial and Dental Genetics, Department of Oral and Craniofacial Sciences, School of Dental Medicine This seminar has been created as a platform for postdoctoral scholars and junior researchers to discuss their research/work, give talks, and have an opportunity for peer discussions. If you are interested in […]
Samantha Totoni, MPH, PhD, Department of Environmental and Occupational Health Research supervision and mentorship in the Public Health Undergraduate Scholars Program This seminar has been created as a platform for postdoctoral scholars and junior researchers to discuss their research/work, give talks, and have an opportunity for peer discussions. If you are interested in showcasing your […]
We will discuss the current landscape of AD diagnosis and staging, who these existing criteria apply to and how were these criteria were generated. The following article will be discussed during the first summer seminar; Jack et al, 2024: Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup For more information regarding […]
The seminar’s focus will be on differences in blood-based biomarker by race/ethnicity, and how representation in study samples and analytic methods may affect our estimates of differences between subgroups. The following articles will be discussed; Alzheimer Disease Blood Biomarker Concentrations Across Race and Ethnicity Groups in Middle-Aged Adults Impact of racialization on neuroimaging and plasma […]
We will be discussing eligibility and recruitment in past and ongoing clinical trials for AD with a focus on implications for clinical care and generating evidence for interventions. For reference on Active Trials: https://www.nia.nih.gov/research/ongoing-AD-trials Anderson TS, Ayanian JZ, Souza J, Landon BE. Representativeness of Participants Eligible to Be Enrolled in Clinical Trials of Aducanumab for […]
We will be discussing AD plasma biomarkers in participants with Down syndrome. Many of our discussions in the past few weeks have centered around how comorbidities and enhanced risk may affect the relationship between biomarker and disease. This week, we will take a closer look at a clinical population that has a genetically determined high risk of AD and […]
